Evidence map›Paper›PMID 39666203›Full record

ArticleClinical & experimental metastasis2024

Molecular characterization of the histopathological growth patterns of colorectal cancer liver metastases by RNA sequencing of targeted samples at the tumor-liver interface.

Emily Latacz, Sanne M L Verheul, Yasmine Sillis, Pieter-Jan van Dam, Michail Doukas, Dirk J Grunhagen, Hanna Nyström, Piet Dirix, Luc Dirix, Steven Van Laere and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & experimental metastasis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Emily Latacz *Translational Cancer Research Unit, Ziekenhuis aan de Stroom (ZAS), Campus Augustinus, Antwerp, Belgium.
Sanne M L Verheul *Department of Gastrointestinal Surgery and Surgical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Yasmine Sillis *Translational Cancer Research Unit, Ziekenhuis aan de Stroom (ZAS), Campus Augustinus, Antwerp, Belgium.
Pieter-Jan van DamData Science, CellCarta NV, Antwerp, Belgium.
Michail DoukasDepartment of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Dirk J GrunhagenDepartment of Gastrointestinal Surgery and Surgical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Hanna NyströmDepartment of Surgical and Perioperative Sciences, Surgery, Umeå University, Umeå, Sweden.
Piet DirixTranslational Cancer Research Unit, Ziekenhuis aan de Stroom (ZAS), Campus Augustinus, Antwerp, Belgium.
Luc DirixTranslational Cancer Research Unit, Ziekenhuis aan de Stroom (ZAS), Campus Augustinus, Antwerp, Belgium.
Steven Van Laere *Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.
Cornelis Verhoef *Department of Gastrointestinal Surgery and Surgical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Peter Vermeulen *Translational Cancer Research Unit, Ziekenhuis aan de Stroom (ZAS), Campus Augustinus, Antwerp, Belgium. peter.vermeulen@zas.be.ORCID 0000-0002-5676-3141

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The behaviour of metastases in patients with liver-metastatic colorectal cancer (CRC) is still not adequately considered during treatment planning. However, studies in large cohorts have shown that the disease course in these patients depends on the histopathological growth pattern (HGP) of the liver metastases, with the desmoplastic (or encapsulated) pattern responsible for a favourable outcome and the replacement pattern for an unfavourable course. To increase our knowledge of cancer biology in general as well as to design clinical trials that take into account the diverse behaviour of liver metastases, it is necessary to know the cellular and molecular determinants of these growth patterns. For that purpose, we compared the transcriptome of tumour tissue (prospective cohort; n = 57) sampled very precisely at the transition of metastasis and adjacent liver, between the desmoplastic and replacement HGP. In addition, the mutational profiles for 46 genes related to CRC were extracted from the RNA sequencing reads. First, we show that the genetic constitution of a liver metastasis from colorectal cancer does not determine its HGP. Second, we show clear differences between HGPs regarding the expression of genes belonging to the Molecular Signatures Database hallmark gene sets. Biological themes of the replacement HGP reflect cancer cell proliferation and glucose metabolism, while the desmoplastic HGP is characterized by inflammation and immune response, and angiogenesis. This study supports the view that HGPs are a reflection of the biology of CRC liver metastases and suggests the HGPs are driven epigenetically rather than by specific gene mutations.

Indexed as

Colorectal NeoplasmsLiver NeoplasmsAgedBiomarkers, TumorCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedMutationProspective StudiesSequence Analysis, RNATranscriptomeBiomarkers, TumorColorectal cancerHistopathological growth patternsLiver metastasisRNA sequencingTranscriptome

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.